Key Highlights

  • UnitedHealth (NYSE:UNH) fell 10.21% on November 18, following a 5.42% decline on November 17, for a two-day loss of about 15%.
  • The stock was the largest drag on the Dow, which fell 561.25 points, or 1.11%, to 50,198.17.
  • CMS has proposed extrapolating Medicare Advantage audit errors to entire plan contracts, starting with 2018 payments.
  • The agency estimates recoveries of about USD 90.2 billion from 2027 through 2036, with comments due on January 19, 2027.

A Second Day of Heavy Selling

UnitedHealth's fall on Wednesday was its second sharp decline in two sessions, after a 5.42% drop on Tuesday. Together, the two days cut about 15% from the stock. Because the Dow is weighted by share price and UnitedHealth carries a high price, the decline accounted for a large part of the index's 561.25 point loss. The Dow closed at 50,198.17, while the S&P 500 slipped only 0.23% and the Nasdaq Composite rose 0.42%, showing how much of the damage was concentrated in health care. The health care sector fell 2.20%, the second weakest of the 11 sectors after energy. Peers were hit as well. Humana fell 12.98%, Elevance Health 7.63%, Centene 7.03% and CVS Health 5.20%. The pattern of losses, with the largest drops in the companies most exposed to Medicare Advantage, showed that investors were pricing a direct Financial Risk rather than a general sector rotation. No large insurer was spared in the selling. The decline also took the stock to one of its lowest levels in several years, a sharp shift for a company long seen as a defensive holding.

What CMS Has Proposed

The Centers for Medicare and Medicaid Services announced on November 16 a proposed rule to recover more improper payments made to Medicare Advantage plans. Under the plan, audit error rates found in a sample of members would be extrapolated to the entire plan contract, rather than limited to the sampled records. The approach would apply starting with payments for 2018. CMS said a federal court in Texas set aside similar provisions of a 2023 rule on procedural grounds, and it proposes to reissue them. The agency estimates that the rule would recover about USD 90.2 billion from 2027 through 2036. The proposal is scheduled for publication in the Federal Register on Thursday, November 19, and public comments are due by January 19, 2027. For UnitedHealth, which runs the largest Medicare Advantage Business in the country, the risk is twofold: possible repayment of past amounts and lower margins on future business if plans must change how they document patient conditions. Investors fear that repayments could be large enough to affect Earnings for several years, even though the rule is still at the proposal stage.

What Investors Will Watch

The rule is a proposal, and the final version could change after the comment period. Insurers are expected to argue that extrapolation is unfair without adjusting for errors in traditional Medicare, a point that featured in earlier legal challenges. Investors will watch for statements from UnitedHealth and its peers on how much of the USD 90.2 billion could fall on them and whether they plan to contest the rule. Industry groups are also likely to press lawmakers, given how many older Americans rely on Medicare Advantage plans. The market backdrop adds pressure. Treasury yields remain near 5.07% on the 10-year note, and the Fed minutes showed that almost all officials expect further rate rises. For income focused investors who hold UnitedHealth for its dividend, the key question is whether the company can keep its payout and buyback plans intact if the rule is finalised. Until there is more clarity, the stock is likely to trade on headlines about the rule and any response from Washington. Any sign of a softer final rule would likely bring buyers back quickly.

Where Things Stand

UnitedHealth has lost about 15% in two days as CMS proposed wider Medicare Advantage audits. The comment period to January 19, 2027 and company responses will shape the next move.